Analysts' Upgrades and Downgrades

Genzyme: Analysts' Upgrades, Downgrades

Stock quotes in this article:GENZ, ESV, AMD 

PetSmart (PETM) price target, estimates boosted at Barclays. PETM price target raised by a dollar to $25 on solid 3Q results. 2010 and 2011 EPS estimates lifted to $1.54 and $1.64, respectively. Equal Weight rating.

PetSmart (PETM) estimates, target boosted at Goldman. Shares of PETM now seen reaching $30. Estimates also increased, as sales trends appear to be bottoming out. Buy rating.

Panera Bread (PNRA) numbers increased at Goldman through 2011. Buyback will add to earnings. Neutral rating and new $70 price target.

Praxair (PX) price target, estimates higher at BofA. Bank of America/Merrill Lynch increased PX price target to $93 from $89. 2009 and 2010 EPS estimate set at $4.00 and $4.55, respectively. Maintain Buy rating.

Salix Pharmaceuticals (SLXP) price target, estimates changed at Credit Suisse. SLXP price target boosted to $33 from $27. 2010 EPS estimate lowered to $0.21, 2011 raised to $1.71. Maintain Outperform rating.

Solarfun Power (SOLF) price target, estimates higher at Barclays. SOLF price target raised to $4 from $3.20 on valuation. 2009 and 2010 EPS estimate increased to -$0.14 from -$0.53 and to $0.40 from $0.10, respectively. Underweight rating.

Tiffany (TIF) price target, estimate boosted at Barclays. Increased TIF price target to $50 from $42 ahead of 3Q earnings. Maintain 2009 EPS estimate at $1.75, 2010 increased to $2.10 from $2. Overweight rating.

Vale (VALE) price target, estimates higher at Barclays. Raised VALE price target to $31 from $28. 2009 and 2010 EPS estimates increased to $1.12 and $1.90, respectively. Maintain Equal Weight rating.

Xcel Energy (XEL) price target, estimate boosted at Barclays. Increased XEL price target to $21 from $19. 2009 EPS estimate maintained at $1.51, 2010 raised to $1.64 from $1.60. Equal Weight rating.

Zimmer (ZMH) estimates reduced at Goldman through 2013. Debt offering at higher interest rates and R&D spending will cut earnings. Buy rating and $66 price target.

>To order reprints of this article, click here: Reprints

This article was written by a staff member of TheStreet.com.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 14.60
Oil *
98.16
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
1.21
10 Yr
1.46%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-7.65%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet